Investigations of Cardiac Functions and Organ Damages in Neonatal Calves with Suscepted Sepsis

Yıl 2020, Cilt: 5 Sayı: 3, 140 - 145, 30.12.2020

Yasemin Beydilli , Halil İbrahim Gökçe

https://doi.org/10.24880/maeuvfd.815632

Öz

ABSTRACT
The aims of the present study were to determine cardiac dysfunction and organ damages in neonatal calves with suspected sepsis. In the study, 20 neonatal calves with suscepted sepsis and 10 clinically healthy neonatal calves were used. Sera were collected from each animal and used to determine cardiac troponin I (cTnI), N-terminal pro-brain natriuretic peptide (NT-proBNP), creatine kinase-myocardial band (CK-MB), lactate dehydrogenase (LDH) and histone H3 levels. In the study, serum levels of cTnI (p<0.05), NT-proBNP (p<0.05), CK-MB (p<0.001), LDH (p<0.001) and histone H3 (p<0.01) were significantly higher in calves with suspected sepsis than those of control calves. Results of the present study indicate that, cardiac functions are impaired, and cardiac and other organ damages are occurred in sepsis suspected neonatal calves. This is the first report that cardiac dysfunction and sepsis-related organ damages were indicated by the elevated NT-proBNP and histone H3 in neonatal calves with suspected sepsis. It is suggestive that, cTnI and NT-proBNP to detect cardiac dysfunction and histone H3 to detect organ damages can be useful as diagnostic and prognostic biomarkers in sepsis suspected calves.

Key words: Calves, cardiac biomarkers, Sepsis.

ÖZ
ABSTRACT
Bu çalışmada sepsis şüpheli neonatal buzağılarda kalp fonksiyon bozuklukları ve organ hasarının belirlenmesi amaçlanmıştır. Çalışmada sepsis şüpheli 20 ve klinik olarak sağlıklı 10 adet neonatal buzağı kullanıldı. Her hayvandan serum örnekleri toplandı ve bu örnekler kardiak troponin I (CTnI), N-terminal pro-natriüretik peptid (NT-proBNP), kreatinin kinaz-myokardial band (CK-MB), laktat dehidrojenaz (LDH) ve histon H3 seviyelerinin belirlenmesinde kullanıldı. Çalışmada, sepsis şüpheli buzağıların serum cTnI (p<0.05), NT-proBNP (p<0.05), CK-MB (p<0.001), LDH (p<0.001) ve histon H3 (p<0.01) düzeylerinin kontrol grubununkilere göre istatistiksel olarak anlamlı düzeyde yüksek olduğu belirlendi. Çalışmada elde edilen sonuçlar, sepsis şüpheli buzağılarda kalp fonksiyonlarının bozulduğunu, kalp ve diğer organlarda hasarın oluştuğunu ortaya koymuştur. Bu çalışma ile ilk defa sepsis şüpheli buzağılarda kalp fonksiyon bozukluğu ve sepsis ilişkili organ hasarları artan serum NT-proBNP ve histon H3 seviyeleri ile belirlenmiştir. Çalışmada elde edilen sonuçlara göre, sepsis şüpheli buzağılarda cTnI ve NT-proBNP kalp fonksiyon bozukluğunun belirlenmesinde ve histon H3 ise organ hasarlarının belirlenmesinde yararlı prognostik ve diyagnostik biyomarkırlar olarak önerilebilir.

Anahtar Kelimeler: buzağı, kardiak biyomarkırlar, sepsis

Anahtar Kelimeler

Calves, Cardiac Biomarkers, Sepsis

Destekleyen Kurum

Mehmet Akif Ersoy Üniversitesi,

Proje Numarası

0467-YL-17

Teşekkür

ACKNOWLEDGEMENT This study was supported by Burdur Mehmet Akif Ersoy University Scientific Research Projects Unit (Master of Science-Project No. 0467-YL-17).

Kaynakça

• 1. Abrams ST, Zhang N, Manson J, Liu T, Dart C, Baluwa F, Wang SS, Brohi K, Anja Kipar A, Yu W, Wang G, Toh CH (2013). Circulating Histones Are Mediators of Trauma-associated Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2013; 187(2): 160-169. DOI: 10.1164/rccm.201206-1037OC.
• 2. Aktas MS, Ozkanlar Y, Oruc E, Sozdutmaz I, Kırbas A. Myocarditis associated with foot-and-mouth disease in suckling calves. Veterinar Ski Arhiv. 2015;85(3): 273-282.
• 3. Alhamdi Y, Abrams ST, Cheng Z, Jing S, Su D, Lui Z, Lane S, Welters I, Wang G, Toh CH. Circulating histones are major mediators of cardiac injury in patients with Sepsis. Crit Care Med 2015; 43(10):2094–103. DOI: 10.1097/CCM.0000000000001162.
• 4. Al-Khafaji AH, Pinsky MR. Multiple Organ Dysfunction Syndrome in Sepsis. http://emedicine.medscape.com/article/169640-overview.(10.043.2016), 2017.
• 5. Angus DC, van der Poll T. Severe Sepsis and Septic Shock. N Engl J Med 2013; 369:2062-2063. DOI: 10.1056/NEJMc1312359.
• 6. Aslani MR, Mohri M, Movassaghi AR. Serum troponin I as an indicator of myocarditis in lambs affected with foot and mouth disease. Vet Res Forum, 2013; 4(1): 59–62.
• 7. Aygun O., Yildiz R. Evaluation of thrombomodulin and pentraxin-3 as diagnostic biomarkers in calves with sepsis. Veterinarni Medicina, 2018; (63), 313–320. DOI:.org/10.17221/159/2017-VETMED.
• 8. Basoglu A, Baspinar N, Tenori L, Hu X, Yildiz R. NMR Based Metabolomics Evaluation in Neonatal Calves with Acute Diarrhea and Suspected Sepsis: A New Approach for Biomarker/S Metabolomics 2014; 4:1-6. DOI: 10.4172/2153-0769.1000134.
• 9. Bay M, Kirk V, Parner J, Hassager C, Nielsen H. et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart. 2003; 89(2):150-4. DOI:10.1136/heart.89.2.150.
• 10. Chen R, Kang R, Fan XG, Tang D. Release and activity of histone in diseases. Cell Death and Disease. 2014; 5:1-9. DOI: 10.1038/cddis.2014.337.
• 11. Chiurcihiu V, Izzi V, D’Aquilio F, Carotenuto F, Di Nardo P, Baldini PM. Brain natriuretic peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages. Regulatory Peptides. 2008;148: 26–32. DOI:10.1016/j.regpep.2008.02.009.
• 12. Cho Y-il, Yoon K-jin. An overview of calf diarrhea-infectious etiology, diagnosis, and intervention. J Vet Sci 2014; 15: 1–17. DOI:10.4142/jvs.2014.15.1.1
• 13. Choon-ngarm T, Partpisanu P. Serum Cardiac Troponin-T as a Prognostic Marker in Septic Shock. J Med Assoc Thai 2008; 91 (12): 1818-22.
• 14. Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA. et al. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association. Circulation. 2017; 135(22):1-38. DOI:10.1161/CIR.0000000000000490.
• 15. Constable, PD, Hinchcliff KW, Done SH, Grünberg W. Veterinary Medicine, A textbook of the diseases of cattle, horses, sheep, pigs and goats 11th ed, Saunders Ltd. China, 2016;57-67.
• 16. Ebisawa T, Ohta Y, Furayoma M, Morita K, Uechi M. Clinical use of N-terminal pro-brain natriuretic peptide concentrations for assesing the severety and prognosis of myxomatous mitral valve disease in dogs. 2012; 10(3): 234-242.
• 17. Ekaney ML, Otto GP, Sossdorf M, Sponholz C, Michael Boehringer M et al. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Critical Care 2014; 18:543. DOI:10.1186/s13054-014-0543-8.
• 18. Fecteau G, Pare J, Van Metre DC, Smith BP, Holmberg CA et al. Use of a clinical sepsis score for predicting bacteraemia in neonatal dairy calves on a calf rearing farm. Can Vet J 1997; 38:101-104.
• 19. Hall C (2004). Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Failure. 6, 257-260. DOI:10.1016/j.ejheart.2003.12.015.
• 20. Hori, Y, Kikuchi M, Nakagawa A, Yonezawa T, Miura H, Ohnami Y. Plasma Atrial Natriuretic Peptide in Healthy Calves and Calves with Congenital Heart Disease. J Vet Intern Med. 2009; 23(3): 653–656. DOI:10.1111/j.1939-1676.2009.0293.x.
• 21. Ibrahim NE, Januzzi JL. Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure. Clinical Chemistry. 2017; 63:211-222. DOI:10.1373/clinchem.2016.259564.
• 22. Kakihana Y, Ito T, Nakahara M, Yamaguchi M, Yasuda T. Sepsis-induced myocardial dysfunction: pathophysiology and management. Journal of Intensive Care, 2016; 4:1-10. DOI: 10.1186/s40560-016-0148-1.
• 23. Kaneko JJ, Harvey JW, Bruss ML. Clinical Biochemistry of Domestic Animals.. 6th ed. AcademicPress, New York. ABD. 2008; p364-390.
• 24. King EG, Bauza GJ, Mella JR, Remick DG. Pathophysiologic mechanisms in septic shock. Lab Invest., 2014; 94(1): 4–12. DOI:10.1038/labinvest.2013.110.
• 25. Klinkon M, Jezek J (2012). Values of blood variables in calves. http://cdn.intechopen.com/pdfs/28679/InTechValues_of_blood_variables_in_calves.pdf. 302-320.
• 26. Kroff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006;92(7): 987-993. DOI:10.1136/hrt.2005.071282.
• 27. Kumar A, Haery C, Parillo JE. Myocardial dysfunction in septic shock. Critical Care Clinics 2000; 16(2):251-287. DOI.org/10.1016/S0749-0704(05)70110-X
• 28. Landesberg G, Levin PD, Gilon D, Goodman S, Georgieva M. et al. Myocardial Dysfunction in Severe Sepsis and Septic Shock: No Correlation With Inflammatory Cytokines in Real-life Clinical Setting. Chest. 2015; 148 (1): 93-102. DOI: 10.1378/chest.14-2259.
• 29. Langhorn R, Willesen JL. Cardiac Troponins in Dogs and Cats. J Vet Intern Med. 2016;30(1):36–50. DOI: 10.1111/jvim.13801.
• 30. Li N, Zhang Y, Fan S, Xing J, Liu H (2013). BNP and NT-proBNP levels in patients with sepsis. Frontier in Bioscience, 18, 1237-1243. DOI.org/10.2741/4175.
• 31. Lima GV and Ferreira FS. N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review. Vet World. 2017;10(9):1072–1082. DOI:10.14202/vetworld.2017.1072-1082.
• 32. Lin CW, Tang W, Wen F, Chen JJ, Zeng XL, Chen Z. Diagnostic Accuracy of NT-ProBNP for Heart Failure with Sepsis in PatientsYounger than 18 Years. Plos One. 2016; 11(1): 1-10. DOI: 10.1371/journal.pone.0147930.
• 33. Lv X, Wang H. Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res. 2016;3: 1-9. DOI:10.1186/s40779-016-0099-9.
• 34. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther 2012; 10(6): 701–706. DOI:10.1586/eri.12.50.
• 35. McDonagh T, Cunningham A, Morrison C, McMurray J, Ford I. et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001; 86(1):21-26. DOI:10.1136/heart.86.1.21.
• 36. MacDonald KA, Kittleson MD, Munro C, Kass P. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J Vet Intern Med. 2003;17(2):172-177. DOI:10.1111/j.1939-1676.2003.tb02430.x
• 37. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M. et al. ESC guide lines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2012; 33(14): 1787-1847. DOI: 10.1093/eurheartj/ehs104.
• 38. Mehta NJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol. 2004; 95(1):13–17. DOI:10.1016/j.ijcard.2003.02.005.
• 39. Nakahara M, Ito T, Kawahara KI, Yamamoto M, Nagasato T et al. Recombinant Thrombomodulin protects mice against histone-induced lethal thromboembolism. PLoS One. 2013; 8(9):e75961, 1-12. DOI: 10.1371/journal.pone.0075961.
• 40. Omar AS, ur Rahman M, Dhatt GS, Salami GO, Abuhasna S. Dynamics of brain natriuretic peptide in critically ill patients with severe sepsis and septic shock. Saudi J Anaesth. 2013; 7(3): 270–276. DOI:10.4103/1658-354X.115347.
• 41. Osterbur K, Mann FA, Kuroki K, DeClue A (2014). Multiple Organ Dysfunction Syndrome in Humans and Animals. J Vet Intern Med., 28, 1141–1151. DOI:10.1111/jvim.12364.
• 42. Pardon B, Deprez P. Rational antimicrobial therapy for sepsis in cattle in face of the new legislation on critically important antimicrobials. Vlaams Diergeneeskundig Tijdschrift, 2018; 87: 37-46.
• 43. Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res 2017; 113(14):1708-1718. DOI: 10.1093/cvr/cvx183.
• 44. Rivers EP, McCord J, Otero R, Jacobsen G, Loomba M. Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med 2007; 22(6):363-73. DOI:10.1177/0885066607307523
• 45. Roberts E, Ludman AJ, Dworzynskisenior A, Al-Mohammad A, Cowie MR. Et al. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ. 2015; 4: 1-16. DOI: 10.1136/bmj.h910.
• 46. Schreiber D, Schraga D. Natriuretic Peptides in Congestive Heart Failure. https://emedicine.medscape.com/article/761722-overview, 2018.
• 47. Sobiech P, Kuleta Z. Activity of LDH isoenzymes in diarrhoeic calves. Bull Vet Inst Pulawy 2006; 50:401-404.
• 48. Spies C, Haude V, Fitzner R, Schröder K, Overbeck M. et al. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest, 1998; 113(4):1055–1063. DOI:10.1378/chest.113.4.1055.
• 49. Undhad VV, Fefar DT, Jivani MB, Gupta H, Ghodasara DJ et al. Cardiac troponin an emerging cardiac biomarker in animal health. Vet World 2012; 5(8):508-511. DOI: 10.5455/vetworld.
• 50. Vincent JL, Sakr Y, Sprung CL. Sepsis in Europeanintensivecareunits: results of the SOAP study. Crit Care Med. 2006; 34(2): 344–353. DOI:10.1097/01.ccm.0000194725.48928.3a.
• 51. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT. Et al. Extracellular histones are major mediators of death in sepsis. Nature Medicine. 2009; 15(11): 1318 – 1321. DOI: :10.1038/nm.2053.
• 52. Yokoyama Y, Takashi Ito T, Yasuda T, Hiroaki Furubeppu H, Kamikokuryo C et al. Circulating histone H3 levels in septic patients are associated with coagulopathy, multiple organ failure, and death: a singlecenter observational study. Thrombosis Journal 2019; 17:1-7. https:// DOI.org/10.1186/s12959-018-0190-4.
• 53. Zhang XH, Dong Y, Chen YD, Zhou P, Wang JD, Wen FQ. Serum N-terminal pro-brain natriuretic peptide level is a significant prognostic factor in patients with severe sepsis among Southwest Chinese Population. Eur Rev Med Pharmacol Sci. 2013;17(4):517-521.